192 related articles for article (PubMed ID: 31064190)
1. Dynamic Changes in Circulating MicroRNA Levels in Liver Cancer Patients Undergoing Thermal Ablation and Transarterial Chemoembolization.
Zavadil J; Juráček J; Čechová B; Andrašina T; Slabý O; Goldberg N
Klin Onkol; 2019; 32(Supplementum1):164-166. PubMed ID: 31064190
[TBL] [Abstract][Full Text] [Related]
2. Thermal Ablation and Transarterial Chemoembolization are Characterized by Changing Dynamics of Circulating MicroRNAs.
Andrasina T; Juracek J; Zavadil J; Cechova B; Rohan T; Vesela P; Paldor M; Slaby O; Goldberg SN
J Vasc Interv Radiol; 2021 Mar; 32(3):403-411. PubMed ID: 33495063
[TBL] [Abstract][Full Text] [Related]
3. Chemoembolization for Treatment of Hepatocellular Carcinoma - National Registry-Based Analysis.
Rohan T; Andrašina T; Uher M; Matkulčík P; Zavadil J; Staňková M; Čechová B; Jandurová L; Válek V
Klin Onkol; 2019; 32(Supplementum1):160-163. PubMed ID: 31064189
[TBL] [Abstract][Full Text] [Related]
4. Circulating MiRNA-373 as a Predictor of Response to Super-selective Transarterial Chemoembolization Bridging Therapy in Hepatocellular Carcinoma Patients Awaiting Liver Transplantation.
Tork ASE; Kamel AAF; Zaki MA; Abo El-Wafa RAH; El-Assar OS; Ibrahim Abdelkarem OA
Asian Pac J Cancer Prev; 2023 Jan; 24(1):291-299. PubMed ID: 36708579
[TBL] [Abstract][Full Text] [Related]
5. Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.
Liu M; Liu J; Wang L; Wu H; Zhou C; Zhu H; Xu N; Xie Y
PLoS One; 2014; 9(10):e109347. PubMed ID: 25275448
[TBL] [Abstract][Full Text] [Related]
6. Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.
Kim SS; Nam JS; Cho HJ; Won JH; Kim JW; Ji JH; Yang MJ; Park JH; Noh CK; Shin SJ; Lee KM; Cho SW; Cheong JY
J Gastroenterol Hepatol; 2017 Jan; 32(1):199-207. PubMed ID: 27194671
[TBL] [Abstract][Full Text] [Related]
7. Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization.
Ali HEA; Emam AA; Zeeneldin AA; Srour R; Tabashy R; El-Desouky ED; Abd Elmageed ZY; Abdel-Wahab AA
Clin Biochem; 2019 Mar; 65():45-52. PubMed ID: 30653948
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
[TBL] [Abstract][Full Text] [Related]
9. Thermal ablation combined with transarterial chemoembolization for hepatocellular carcinoma: What is the right treatment sequence?
Hendriks P; Sudiono DR; Schaapman JJ; Coenraad MJ; Tushuizen ME; Takkenberg RB; Oosterveer TTM; de Geus-Oei LF; van Delden OM; Burgmans MC
Eur J Radiol; 2021 Nov; 144():110006. PubMed ID: 34717187
[TBL] [Abstract][Full Text] [Related]
10. Utilization of Next Generation Sequencing in Analysis of Circulating MicroRNAs as Predictive Biomarkers for Patients with Locally Advanced Rectal Carcinoma.
Macháčková T; Grolich T; Fiala L; Procházka V; Škrovina M; Kala Z; Slabý O
Klin Onkol; 2019; 32(Supplementum1):157-159. PubMed ID: 31064188
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
Thornton LM; Cabrera R; Kapp M; Lazarowicz M; Vogel JD; Toskich BB
Curr Probl Diagn Radiol; 2017; 46(6):402-409. PubMed ID: 28392205
[TBL] [Abstract][Full Text] [Related]
12. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
Chen QF; Jia ZY; Yang ZQ; Fan WL; Shi HB
Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1748-1755. PubMed ID: 28681222
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma.
Iezzi R; Pompili M; La Torre MF; Campanale MC; Montagna M; Saviano A; Cesario V; Siciliano M; Annicchiarico E; Agnes S; Giuliante F; Grieco A; Rapaccini GL; De Gaetano AM; Gasbarrini A; Bonomo L;
Dig Liver Dis; 2015 Mar; 47(3):242-8. PubMed ID: 25577299
[TBL] [Abstract][Full Text] [Related]
14. Single-session transarterial chemoembolization combined with percutaneous thermal ablation in liver metastases 3 cm or larger.
Kobe A; Tselikas L; Deschamps F; Roux C; Delpla A; Varin E; Hakime A; De Baère T
Diagn Interv Imaging; 2022 Nov; 103(11):516-523. PubMed ID: 35715327
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.
Tacher V; Lin M; Duran R; Yarmohammadi H; Lee H; Chapiro J; Chao M; Wang Z; Frangakis C; Sohn JH; Maltenfort MG; Pawlik T; Geschwind JF
Radiology; 2016 Jan; 278(1):275-84. PubMed ID: 26131913
[TBL] [Abstract][Full Text] [Related]
16. Serum microRNA-210 as a predictive biomarker for treatment response and prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Zhan M; Li Y; Hu B; He X; Huang J; Zhao Y; Fu S; Lu L
J Vasc Interv Radiol; 2014 Aug; 25(8):1279-1287.e1. PubMed ID: 24935355
[TBL] [Abstract][Full Text] [Related]
17. Survival of Patients with Colorectal Liver Metastases after Transarterial Chemoembolization Using Irinotecan-Eluting Microspheres: A Single-Center Retrospective Analysis Comparing RECIST 1.1 and Choi Criteria.
Maraj T; Mirrahimi A; Dey C
J Vasc Interv Radiol; 2023 Jun; 34(6):983-990.e1. PubMed ID: 36775014
[TBL] [Abstract][Full Text] [Related]
18. Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients.
E Abdelaziz H; El-Guendy N; Radwan EM; Sharawi SK; El-Houseini ME; Abdel-Wahab AA
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4125-4135. PubMed ID: 36579994
[TBL] [Abstract][Full Text] [Related]
19. Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats.
Vogl TJ; Qian J; Tran A; Oppermann E; Naguib NN; Korkusuz H; Nour Eldin NE; Bechstein WO
Diagn Interv Radiol; 2017; 23(2):150-155. PubMed ID: 28185998
[TBL] [Abstract][Full Text] [Related]
20. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
